Abivax SA (ABVX)

Abivax Announces Closing of $920 Million Public Offering

Abivax Announces Closing of $920 Million Public Offering PARIS, France, July 6, 2026 –10:05 p.m. CEST – Abivax...

Form 424B5 - Prospectus [Rule 424(b)(5)]

Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M)

Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of...

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Correction: Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares

Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of American...

Abivax announces trading resumption of its ordinary shares on Euronext Paris

Abivax announces trading resumption of its ordinary shares on Euronext Paris PARIS, France, July 1, 2026 –...

Abivax Announces Pricing of Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares

Abivax Announces Pricing of Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary...

Abivax announces temporary trading halt of its ordinary shares on Euronext Paris

Abivax announces temporary trading halt of its ordinary shares on Euronext Paris PARIS, France, July 1, 2026 –...

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Form 424B5 - Prospectus [Rule 424(b)(5)]

Abivax Announces Launch of Public Offering of American Depositary Shares

Abivax Announces Launch of Public Offering of American Depositary Shares PARIS, France – June 30, 2026 – 10:45...

Form POSASR - Post-effective Amendment to an automatic shelf registration statement

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance Safety Database

Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical...

Abivax Investigation Initiated: SueWallSt Investigates the Officers and Directors of Abivax (ABVX)

Abivax Investigation Initiated: SueWallSt Investigates the Officers and Directors of Abivax (ABVX) PR...